The diagnosis of cardiac sarcoidosis (CS) is challenging. Recently, guidelines incorporated cardiac positron emission tomography (PET) with 18F-Fluorodeoxyglucose (F18-FDG) as a non-invasive diagnostic modality for the detection and follow-up of CS. However, this technique is dependent of patient dietary preparation to suppress physiological myocardial F18-FDG uptake. We present a case of possible CS which highlights a novel preparation protocol that facilitated appropriate myocardial suppression.
Keywords: Image guided application; Inflammation; PET; diseases/processes; imaging agents; metabolism; modalities; outcomes; sarcoid heart disease; tracers.
© 2020. American Society of Nuclear Cardiology.